A. Z. , D. Mc, M. L. , and P. Jc, Conduite à tenir devant une recherche d'anticorps antinucléaires positive. Médecine thérapeutique, Démarches diagnostiques, pp.801-805, 1998.

A. R. Bougie-d, Drug-induced immune thrombocytopenia, N Engl J Med, vol.357, pp.580-587, 2007.

B. Revue-de-médecine-interne, . Commitee, . Standards, . Haematology, . Haematology et al., Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy Bleedind signs in children with idiopathic thrombocytopenic purpura, Br J Haematol J Pediatr Hematol Oncol, vol.120, issue.25, pp.574-596, 2003.

C. Y. , D. B. Shamai-lubovitz-o, C. L. Mozes-b, . Cooper-n, P. L. Klein-r et al., The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients wih persistent low platelet counts Eltrombopag -a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations. Drug design, development and therapy Rituximab combination therapy in relapsing multiple sclerosis Rituximab: mode d'action et de résistance. Bull cancer, 26 DELMAS Y. et al. Le CD154 plaquettaire: une nouvelle interface dans l'hémostase et la réaction inflammatoire. M/S: Médecine Sciences, pp.1630-1638, 2000.

E. Ms, E. , M. M. , and L. M. , Overwhelming postsplenectomy infection: is quality of patient knowledge enough for prevention? Long-term salvage therapy with cyclosporin an in refractory idiopathic thrombocytopenic purpura, High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura, pp.77-80, 2002.

J. Br, F. O. Haematology, G. D. Rosenthal-e-fillatreau-s, and . Anderton-s, 31 EUROPEAN MEDICINES AGENCY (EMEA) Nplate® (romiplostim) Résumé du rapport européen public d'évaluation Actualité dans la prise en charge du Purpura Thrombopénique Idiopathique Revue de médecine interneNot always the bad guys: B cells as regulators of autoimmune pathology, Nature Reviews Immunology, vol.136, issue.3, pp.309-314, 1999.

G. Mh, V. Ji, W. G. , P. C. , K. J. et al., Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial, N Engl J Med, vol.19, issue.25, pp.314-1593, 1986.

G. Jn, Drug-induced thrombocytopenia: a systematic review of published case reports, Ann Intern Med, vol.129, pp.886-890, 1998.

G. J. , M. S. Go, G. B. Ghanima-w, C. D. Bussel, K. Kk et al., Improved quality of life for romiplostimtreated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment Management of idiopathic thrombocytopenicpurpura in pregnancy, Br J Hematol Blood. Semin Hematol, vol.144, issue.37, pp.409-415, 2000.

A. Revue-de-médecine-interne, . S. De, . Hershko-c-r, and . Quan-d, Avis de la Commission de Transparence Azathioprine Avis de la Commission de Transparence Eltrombopag. juin 2010, 1-18. 48 HAUTE AUTORITE DE SANTE (HAS) Avis de la Commission de Transparence Romiplostim. juin 2009, 1-15. 49 HAUTE AUTORITE DE SANTE (HAS) Avis de la Commission de Transparence Vincristine Purpura immunologique de l'enfant et de l'adulte Use of danazol in the management of chronic idiopathic thrombocytopenic purpura TextBook of therapeutics: drug and Disease management, Protocole National de Diagnostic et de Soins (PNDS), octobre 2009 Lippincott Willams & Wilkins. 2006. 53 HE R, REID D. & JONES C. Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura. Blood, pp.9-10, 1985.

J. F. L-'hémostase, Les Presses de l'Université Laval, pp.237-247, 1995.

K. M. , M. M. , B. P. Godeau-b, K. V. Le-purpura-thrombopénique-immunologique, S. S. et al., Les nouveautés thérapeutiques dans le purpura thrombopénique immunologique: les agonistes du récepteur de la thrombopoïétine Revue de médecine interne Encyclopédie Orphanet Grand Public. 2010. 62 KHELLAF M. Prise en charge du purpura thrombopénique immunologique de l'adulte. Revue de médecine interne Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies Efficacy of mycophenolate mofetil in adult refractory autoimmune cytopenias: a single center preliminary study, Blood. Eur J Haematol, vol.30, issue.1, pp.13-15, 1987.

M. F. Schneider-p, Cracking the BAFF code, Nature Immunology, vol.9, pp.491-502, 2009.

M. Mh, D. Peixoto-rde-l, M. M. Lima-cp, S. L. , and C. Pdo-s, Predisposition to idiopathic thrombocytopenic purpura maps close to the major histocompatibility complex class I chain-related gene A. Hum Immunol Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long term results, 72 MALOISEL F. et al. Purpura thrombopénique idiopathique et grossesse : expérience personnelle et revue de la littérature. Médecine thérapeutique, pp.179-183, 2004.

K. Mccrae, Thrombocytopenia in pregnancy: differential diagnosis, pathogenesis, and management, Blood Reviews, vol.17, issue.1, pp.7-14, 2003.
DOI : 10.1016/S0268-960X(02)00056-5

R. Mcmillan, Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura, American Journal of Hematology, vol.16, issue.2, pp.150-154, 2008.
DOI : 10.1002/ajh.20992

R. Mcmillan and W. L. Tomer, Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents. Biologics: targets & therapy, pp.1364-1369, 2004.

M. M. Moutet-a and F. P. , Immune thrombocytopenic purpura: epidemiology and implications for treatment Pregnancy in women with immune thrombocytopenic purpura, Eur J Haematol Arch Intern Med, vol.71, issue.10, pp.3-7, 1990.

N. Aj, Clinically significant newly presenting auto-immune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients, Br J Haematol, vol.122, issue.6, pp.966-974, 2003.

. Olsson-b, T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura, Nature Medicine, vol.56, issue.9, pp.1123-1124, 2003.
DOI : 10.1111/j.1600-0609.1996.tb00298.x

P. C. Pierrot-deseilligny-despujol-c, M. M. , and K. M. , La recherche d'anticorps anti-glycoprotéines plaquettaires, EFS, vol.94, pp.1-27, 2010.

J. , W. Rg, K. Hc, and . Brand, Morbidity and mortality in adults with idiopathic thrombocytopenic purpura, Blood, vol.97, pp.1-5, 2001.

P. D. , B. T. , and E. Ml, Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults, Haematologica, issue.12, pp.92-1695, 2007.

R. M. Ayme-s-a, G. T. Slichter-s-rodeghiero-f, and S. R. , Centres de référence labellisés et centres de compétence désignés pour la prise en charge d'une maladie rare ou d'un groupe de maladies rares. Les cahiers d'Orphanet Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura. Blood Treatment of immune thrombocytopenic purpura: focus on eltrombopag Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group, Biologics: targets & therapy Blood, vol.85, issue.113, pp.2-103, 1995.

E. Masson, S. H. , and G. G. , Immune thrombocytopenia in children and adults: what's the same, what's different? Haematologica, 109 SEBAHOUN G. Purpura thrombopénique auto-immun. Hématologie clinique et biologique. Edition Arnette. 1998, 2 ème édition, pp.84-92, 2008.

S. Jb and P. Nr, Prevalence of immune thrombocytopenia: analyses of administrative data, J Thromb Haemost, vol.4, pp.2377-2783, 2006.

S. J. Surveillance-et-précautions-À-prendre-lors-d-'un-traitement-par-un-immunomodulateur-biologique, S. Française-d-'hematologie-et-d-'immunologie-pediatrique, . Societe-française-d-'hematologie-et-d-'immunologie-pediatrique, B. J. Spelman-d, D. A. Isaacs-d et al., Revue de médecine interneSHIP) Recommandations de prise en charge d'un PTI aigu de l'enfant Purpura thrombopénique idiopathique de l'enfant: mesures d'accompagnements for Infectious Diseases. Guidelines for the prevention of sepsis in asplenic and hyposplenic patients, Intern Med J, vol.112, issue.1145, pp.315-318, 2007.

. Hématologie, 124 VIALLARD J. Prise en charge diagnostique et thérapeutique du purpura thrombopénique idiopathique. Revue de médecine interne, pp.141-149, 2002.

. Médecine-thérapeutique, 126 ZARANDONA J. & YAZER M. The role of the Coombs test in evaluating hemolysis in adults, CMAJ, vol.14, issue.74, pp.96-104, 2006.

. Zeller-b, Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease Acta Paediatr The effects of BAFF and BAFF-RFc fusion protein in immune thrombocytopenia, 170 DOCUMENTS PROVENANT DE LABORATOIRES: 129 LABORATOIRE AMGEN. Nplate (romiplostim): guide d'information à destination des prescripteurs, pp.178-184, 2005.

L. Amgen, Soins de support et thérapies ciblées; Amgen, l'innovation en biotechnologie dans le traitement du cancer. 131 LABORATOIRE AMGEN. Informations importantes sur le bon usage du traitement par Nplate (romiplostim), 2011.

L. Amgen, Nplate (romiplostim) -Modification des modalités d'adaptation posologique chez les patients présentant un PTI et des mises en garde concernant les patients insuffisants hépatiques présentant un PTI, 133 LABORATOIRE GSK. Une nouvelle option thérapeutique contre le purpura thrombocytopénique idiopathique (PTI) chronique est approuvée au Canada. 2011 134 LABORATOIRE GSK. Revolade (eltrombopag) MOA video, 2010.

S. Internet-consultes, 135 http://fondation-maladiesrares.org, 2012.